Moreover, we reported that the cardiac glycosides ouabain and digoxin showed increased sensitivity in ERα-positive BC cancer cell lines compared to ERα-negative ones because, in addition to inhibiting the Na/K ATPase, they hyperactivated the 26S proteasome, inducing receptor degradation9,13. This evidence concerns the gene ESR1 and breast cancer.